UNC startup GeneVentiv Therapeutics is developing the first universal, single-dose gene therapy for all types of hemophilia, including the toughest cases.

Why is UNC-Chapel Hill poised to make a growing impact through innovation and entrepreneurship? Two leaders of Innovate Carolina talk partnerships, team-driven innovation and new ways the University is expanding innovation for all.

UNC-Chapel Hill, Duke University and the North Carolina Biotechnology Center highlight the importance of strengthening a regional ecosystem of scientific and entrepreneurial expertise by helping life science startups gain exposure, build connections, and get feedback from potential investors.

UNC startup Pulvinar Neuro’s novel treatment for mental illness – a technology that uses closed-loop, non-invasive stimulation of brain waves – offers hope to a rising tide of patients and recently led to the company’s acquisition by medical device leader Electromedical Products International.

A UNC biomedical engineering professor’s knack for entrepreneurial resourcefulness helped him jumpstart the development of an innovative face mask device – and a new startup company.

Funded by the U.S. EDA Sprint Challenge award, the new hub will boost economic development in the Research Triangle by providing startups with entrepreneurial advisers, a joint talent network and access to service providers.

How are a new group of UNC graduate students and postdoctoral fellows accelerating the pace of progress for faculty inventors-turned-entrepreneurs? The insights they deliver are adding up to breakthrough therapies, disruptive treatments and novel technologies.

UNC-affiliated startup RainBio is changing the landscape of ocular gene therapy with its novel treatment to reverse and prevent blindness in children with rare genetic diseases.

Michael Ramsey, Ph.D. will be recognized as the UNC Inventor of the Year at the 2020 Celebration of Inventorship, which honors UNC-Chapel Hill researchers for their contributions to inventions and patents.

The first two UNC-Chapel Hill faculty research projects funded by Pinnacle Hill are underway. How is the company supporting the development of new medicines – and what’s next for this Carolina-Deerfield partnership?